Transarterial chemoembolization (TACE) combined with apatinib versus TACE combined with sorafenib in advanced hepatocellular carcinoma patients: a multicenter retrospective study

BACKGROUND: The combination of transarterial chemoembolization (TACE) with sorafenib has demonstrated superior efficacy over sorafenib and TACE monotherapy in hepatocellular carcinoma (HCC). Apatinib, a new targeted agent, has been recently reported to prolong the survival of HCC patients, either al...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Ann Transl Med
Autors principals: Qiu, Zhiyu, Shen, Lujun, Jiang, Yiquan, Qiu, Jiliang, Xu, Zining, Shi, Mengting, Yu, Zhentao, Ma, Yanping, He, Wei, Zheng, Yun, Li, Binkui, Wang, Guoying, Yuan, Yunfei
Format: Artigo
Idioma:Inglês
Publicat: AME Publishing Company 2021
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7944263/
https://ncbi.nlm.nih.gov/pubmed/33708910
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm-20-5360
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars